Skip To Main Content
Lilly
Menu closed
Lilly
  • Account Login / Register
  • Medical Home
    • Medical Information
  • Medical Education
  • Science
Ask Lilly

We're here to help.

Chat
Chat with us Chat with us
Question Contact Us
Expand contact lilly
Lilly

You are now leaving the LillyMedical.com website

The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to LillyMedical.com.

  1. Medical Information Right
  2. Oncology Right
  3. Jaypirca (pirtobrutinib) tablets Right
  4. Does Jaypirca™ (pirtobrutinib) affect fertility?
Search Jaypirca (type in keywords)
Search Medical Information

If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)

Loading icon

Jaypirca ™ (pirtobrutinib) tablets

50 mg,100 mg

Full Prescribing Information

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

Does Jaypirca™ (pirtobrutinib) affect fertility?

The effect of Jaypirca (pirtobrutinib) on fertility has not been studied. In toxicity studies conducted in rats and dogs, pirtobrutinib did not effect male or female reproductive organs.

US_cFAQ_PIR027_FERTILITY
cFAQ
cFAQ
US_cFAQ_PIR027_FERTILITY
en-US

Effect of Pirtobrutinib on Fertility

Studies to assess the effects of pirtobrutinib on fertility have not been performed.1 

In repeat-dose toxicity studies of up to 3-months duration conducted with pirtobrutinib in rats and dogs, no effects on male or female reproductive organs were identified.1

Enclosed Prescribing Information

JAYPIRCA™ (pirtobrutinib) tablets, for oral use, Lilly

Reference

1Jaypirca [package insert]. Indianapolis, IN: Eli Lilly and Company; 2023.

Date of Last Review: January 10, 2023

Are you satisfied with this content?

Can't find what you're looking for? Contact us for answers to your medical questions.

  • Copyright
  • Terms of Use
  • Privacy Statement
  • Accessibility Statement
  • Sitemap

    This site is intended for US Healthcare Professionals only.

    4.0.17 02/2023 | GLOOTH00001 04/2015 | © Lilly USA, LLC 2023. All rights reserved.

    Product names listed above are trademarks or registered trademarks owned by or licensed to Eli Lilly and Company, its subsidiaries, or affiliates

    facebook twitter linkedin
    visit www.phactmi.org
    Lilly